Avenzo Therapeutics Recruiting Site

Columbus, Ohio 43221

1 studies enrolling now · 1 studies all time

What they study most

HR+, HER2-, Advanced Breast Cancer, HR+/HER2- Breast Cancer

Studies at this site

• ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid Tumors — Recruiting now